| |
Mean
|
Median
|
Min
|
Max
|
SD
|
Reference value
|
No. of subjects with abnormal values
|
|---|
|
FSH (mlU/ml)
|
4.94
|
5.18
|
1.32
|
9.42
|
2.01
|
3.5—12.5*
|
9↓
|
|
LH (mlU/ml)
|
11.43
|
8.43
|
0.20
|
27.73
|
7.64
|
2.4—12.6*
|
12↑, 3↓
|
|
LH/FSH
|
2.38
|
2.19
|
0.15
|
8.54
|
1.71
|
≤ 2 [22]
|
15↑
|
|
estradiol (pg/ml)
|
66.84
|
45.44
|
12.55
|
236.40
|
56.71
|
12.5–166* (folicular phase)
|
4↑
|
|
TT (ng/dl)
|
53
|
49
|
6
|
118
|
20
|
< 51 [23]
|
14↑
|
|
SHBG (nmol/l)
|
56.86
|
47.55
|
20.21
|
176.10
|
33.21
|
26.1–110*
|
5 ↓ 1↑
|
|
FAI
|
4.32
|
3.60
|
0.64
|
12.00
|
2.99
|
≤ 4.4 [21]
|
10 ↑
|
|
DHEA-S (µmol/l)
|
6.96
|
5.94
|
2.17
|
12.14
|
2.81
|
1.77–9.99 *
|
7↑
|
|
cortisol (morning sample) (nmol/l)
|
395.40
|
431.70
|
105.10
|
575.00
|
121.57
|
166–507*
|
2↓ 6↑
|
|
cortisol (evening sample) (nmol/l)
|
80.21
|
56.95
|
15.37
|
300.70
|
70.24
|
74–291*
|
17↓1↑
|
|
fasting glucose (mg/dl)
|
87.77
|
87.40
|
78.80
|
99.00
|
5.22
|
60–99*
|
0↑
|
|
fasting insulin (mU/ml)
|
14.55
|
14.76
|
3.78
|
31.51
|
6.37
|
2.6–24.9*
|
2↑
|
|
HOMA-IR
|
3.17
|
3.20
|
0.34
|
7.05
|
1.51
|
< 2.32 [20]
|
23↑
|
|
TC (mg/dl)
|
156.91
|
157.70
|
120.50
|
208.10
|
24.09
|
< 190*
|
3↑
|
|
HDL-C (mg/dl)
|
54.82
|
55.60
|
38.90
|
73.20
|
8.65
|
≥ 45*
|
2↓
|
|
LDL-C (mg/dl)
|
83.51
|
79.50
|
44.30
|
130.60
|
20.71
|
< 115*
|
3↑
|
|
TG (mg/dl)
|
92.92
|
84.50
|
46.70
|
201.90
|
37.46
|
< 150*
|
3↑
|
- FSH, follicle-stimulating hormone; LH, luteinizing hormone; IU, international units; TT, total testosterone; FAI, free androgen index; SHGB, sex hormone-binding globulin; DHEA-S, dehydroepiandrosterone sulfate; HOMA-IR, Homeostatic Model Assessment of Insulin Resistance; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides
- *According to the hospital age- and sex-specific laboratory reference ranges, ↑above, ↓below the reference values
